|
Real-time Estimate
Cboe BZX
12:43:54 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 2.055 USD | +0.74% |
|
-0.72% | -43.85% |
Company Valuation: Fortress Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 68.04 | - |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -40.11% | - |
| Enterprise Value (EV) | 249.1 | 71.14 | 54.57 | 55.9 | 113.6 | 68.04 | 68.04 |
| Change | - | -71.44% | -23.29% | 2.43% | 103.22% | -40.11% | 0% |
| P/E | -3.16x | -0.68x | -0.36x | -0.75x | -52.3x | 0.8x | -2.04x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0x | 0.5x | -0x | 0x |
| Capitalization / Revenue | 3.62x | 0.94x | 0.65x | 0.97x | 1.8x | 0.86x | 0.6x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.86x | 0.6x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2.07x | -4.22x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -11.85 | -14.55 | -8.47 | -2.69 | -0.07 | 2.55 | -1 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 68.79 | 75.74 | 84.51 | 57.68 | 63.26 | 78.79 | 113.2 |
| EBITDA | -188.5 | - | - | -107.3 | -65.56 | - | - |
| EBIT 1 | -188.5 | -203.6 | -142.3 | -110.4 | -70.22 | -32.9 | -16.11 |
| Net income 1 | -64.7 | -86.58 | -68.67 | -46 | -1.882 | 88.25 | -37.81 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 37.500 | 9.825 | 3.010 | 2.025 | 3.660 | 2.040 | 2.040 |
| Nbr of stocks (in thousands) | 6,642 | 7,241 | 18,131 | 27,605 | 31,038 | 33,351 | - |
| Announcement Date | 3/28/22 | 3/30/23 | 3/28/24 | 3/31/25 | 3/31/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.8x | - | - | - | 68.04M | |
| 33.76x | 12.26x | 24.76x | 0.58% | 1,060B | |
| 28.75x | 6.35x | 18.21x | 2.07% | 623B | |
| 34.38x | 7.99x | 16.52x | 2.56% | 480B | |
| 103.88x | 5.82x | 24.82x | 2.39% | 352B | |
| 19.43x | 4.75x | 11.8x | 2.78% | 345B | |
| 20.28x | 5.28x | 13.08x | 3.01% | 274B | |
| 20.79x | 4.27x | 12.2x | 2.08% | 249B | |
| 26.09x | 6.8x | 12.11x | 2.44% | 223B | |
| -44.42x | 6.54x | 25.48x | 2.24% | 182B | |
| Average | 24.37x | 6.67x | 17.66x | 2.24% | 378.81B | |
| Weighted average by Cap. | 32.19x | 7.84x | 19.08x | 1.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBIO Stock
- Valuation Fortress Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
